FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
FDA’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.
Patrizia Cavazzoni Drug Research Drug Administration Center Public Health Emergency Drug Administration Drug Evaluation
Source: fda.gov